View in EDS HTML Full Text PDF Full Text

Prospective systematic classification of causes of death in the course of multiple myeloma.

Saved in:
Bibliographic Details
Title: Prospective systematic classification of causes of death in the course of multiple myeloma.
Authors: Jin JX; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany., Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Yilmaz B; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Bertsch U; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Gu KJ; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany., Hanoun C; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Mann C; Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Schroers R; Hematology and Oncology, Knappschaft Kliniken, University Hospital Bochum, Bochum, Germany., von Metzler I; Goethe-University Frankfurt, University Hospital, Department of Medicine II - Hematology and Oncology, Frankfurt am Main, Germany., Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany., Klein EM; Department of Internal Medicine 5, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany., Hoffmann M; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany., Lutz C; Hematology / Oncology Center, Koblenz, Germany., Riesenberg H; Hematology / Oncology Center, Bielefeld, Germany., Martens UM; Hematology, Oncology, Palliative Care, SLK-Clinics Heilbronn, Heilbronn, Germany., Michel CS; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany., Kunz C; Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany., Shumilov E; Medical Clinic A, University Hospital Münster, Münster, Germany., Gezer D; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany., Trautmann-Grill K; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Müller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and BMT with Department of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
Source: Blood cancer journal [Blood Cancer J] 2025 Oct 20; Vol. 15 (1), pp. 167. Date of Electronic Publication: 2025 Oct 20.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2044-5385
DOI:10.1038/s41408-025-01380-z